TY - JOUR
AU - B. H. Lambdin
AU - L. Wenger
AU - R. Bluthenthal
AU - T. S. Bartholomew
AU - H. E. Tookes
AU - P. LaKosky
AU - S. O'Neill
AU - A. H. Kral
A1 - 
AD - RTI International, Berkeley, CA, USA. blambdin@rti.org.; University of California San Francisco, San Francisco, CA, USA. blambdin@rti.org.; University of Washington, Seattle, WA, USA. blambdin@rti.org.; RTI International, Berkeley, CA, USA.; University of Southern California, Los Angeles, CA, USA.; University of Miami, Miami, FL, USA.; North American Syringe Exchange Network, Tacoma, WA, USA.; National Harm Reduction Coalition, Oakland, CA, USA.
AN - 36855181
BT - Harm Reduct J
C5 - Opioids & Substance Use
CP - 1
DA - Feb 28
DO - 10.1186/s12954-023-00755-4
DP - NLM
ET - 20230228
IS - 1
JF - Harm Reduct J
LA - eng
PY - 2023
SN - 1477-7517
SP - 26
ST - How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
T1 - How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
T2 - Harm Reduct J
TI - How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
U1 - Opioids & Substance Use
U3 - 10.1186/s12954-023-00755-4
VL - 20
VO - 1477-7517
Y1 - 2023
ER -